Skip to content

The efficacy of Chuna therapy for chronic obstructive pulmonary disease

The effectiveness and safety of Chuna manual therapy adjuvant to Western medicine in patients with chronic obstructive pulmonary disease: study protocol for a randomized, single-blind, investigator-initiated, pilot trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006119
Enrollment
40
Registered
2021-05-06
Start date
2021-07-03
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : The CT is performed on the primary and accessory respiratory muscles. The CT in this study is given to all subjects in the same way from the first to the tenth method, the details of which ar

Sponsors

Kyung Hee University Oriental Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged between 40 – 80 years 2) Patients who satisfy the COPD clinical diagnostic criteria (FEV1/FVC<0.70 [GOLD] on the Spirometry) and receiving the standard drug therapy 3) Patients who voluntarily signs and submits the written consent for participation in the present clinical study

Exclusion criteria

Exclusion criteria: 1) Individuals with comorbidity of severe respiratory disease other than COPD (cystic fibrosis, pneumonia, ILD, lung cancer, etc.) 2) Individuals with a history of alcohol or other substance abuse or dependency 3) Individuals showing a clinically significant disease or disorder of the liver, kidneys, cardiovascular system, respiratory system, endocrine system, and central nervous system, based on the results of the physicochemical test and clinical examination, and those with a history of malignant tumor or mental disorder (Here, individuals without 5-year postoperative recurrence are allowed to participate) 4) Individuals showing a change of drug use within the past three months prior to the present study 5) Individuals who are unable to walk independently 6) Individuals who have received kinetic, physical, or manual therapy related to respiratory rehabilitation within the past month 7) Individuals who are currently receiving an oxygen therapy 8) Individuals with symptoms that prevent the use of CT 9) Individuals who are pregnant or planning a pregnancy 10) Individuals who are deemed unsuitable for the clinical study by the principal investigator

Design outcomes

Primary

MeasureTime frame
6-minute walk test

Secondary

MeasureTime frame
Pulmonary function test (FEV1, FVC, FEV1/FVC);mMRC (Modified Medical Research Council;dyspnea VAS (Visual analog scale);SGRQ (St George's respiratory questionnaire);CAT (COPD Assessment Test);EQ-5D ( Euro Quality of Life-5 dimension)

Countries

Korea, Republic of

Contacts

Public ContactKwan-Il Kim

Kyung Hee University Oriental Medical Center

myhappy78@naver.com+82-2-958-1892

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 14, 2026